SE7700098L - Bedovningsmedel och forfarande for framstellning derav - Google Patents
Bedovningsmedel och forfarande for framstellning deravInfo
- Publication number
- SE7700098L SE7700098L SE7700098A SE7700098A SE7700098L SE 7700098 L SE7700098 L SE 7700098L SE 7700098 A SE7700098 A SE 7700098A SE 7700098 A SE7700098 A SE 7700098A SE 7700098 L SE7700098 L SE 7700098L
- Authority
- SE
- Sweden
- Prior art keywords
- alpha
- annostics
- procedures
- manufacture
- hydrogen atom
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 241000284708 Sarcophaga alpha Species 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 150000001441 androstanes Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003128 pregnanes Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
- C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB357/76A GB1570394A (en) | 1976-01-06 | 1976-01-06 | 11-acyloxy-3-hydroxy steroids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7700098L true SE7700098L (sv) | 1977-07-07 |
Family
ID=9702974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7700098A SE7700098L (sv) | 1976-01-06 | 1977-01-05 | Bedovningsmedel och forfarande for framstellning derav |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS5285159A (OSRAM) |
| AU (1) | AU513579B2 (OSRAM) |
| BE (1) | BE850108A (OSRAM) |
| CA (1) | CA1084903A (OSRAM) |
| DE (1) | DE2700267A1 (OSRAM) |
| DK (1) | DK3577A (OSRAM) |
| FR (1) | FR2361419A1 (OSRAM) |
| GB (1) | GB1570394A (OSRAM) |
| NL (1) | NL7700054A (OSRAM) |
| NZ (1) | NZ183004A (OSRAM) |
| SE (1) | SE7700098L (OSRAM) |
| ZA (1) | ZA7759B (OSRAM) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ300694A3 (en) * | 1993-12-02 | 1996-05-15 | Akzo Nobel Nv | Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof |
| GB0105772D0 (en) * | 2001-03-08 | 2001-04-25 | Sterix Ltd | Use |
| CN104136452A (zh) | 2011-10-14 | 2014-11-05 | 萨奇治疗股份有限公司 | 3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途 |
| DK2806877T3 (da) | 2012-01-23 | 2019-11-04 | Sage Therapeutics Inc | Neuroaktive steroidformuleringer omfattende et kompleks af allopregnanolon og sulfobutylether beta-cyclodekstrin |
| CA2882708A1 (en) | 2012-08-21 | 2014-02-27 | Sage Therapeutics, Inc. | Methods of treating epilepsy or status epilepticus |
| EP2986623B1 (en) | 2013-04-17 | 2018-11-07 | Sage Therapeutics, Inc. | 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof |
| SI2986624T1 (sl) | 2013-04-17 | 2020-10-30 | Sage Therapeutics, Inc. | 19-nor nevroaktivni steroidi za metode zdravljenja |
| US9725481B2 (en) | 2013-04-17 | 2017-08-08 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| SI3021852T1 (sl) * | 2013-07-19 | 2021-07-30 | Sage Therapeutics, Inc. | Nevroaktivni steroidi, sestavki in uporabe le-teh |
| JP6466942B2 (ja) | 2013-08-23 | 2019-02-06 | セージ セラピューティクス， インコーポレイテッド | 向神経活性ステロイド、組成物、及びその使用 |
| WO2015195962A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| EP4527461A3 (en) | 2014-10-16 | 2025-06-25 | Sage Therapeutics, Inc. | A compound, compositions thereof and this compound for use in methods of treating cns disorders |
| RS60642B1 (sr) | 2014-10-16 | 2020-09-30 | Sage Therapeutics Inc | Kompozicije i postupci za lečenje poremećaja cns-a |
| SMT202000276T1 (it) | 2014-11-27 | 2020-07-08 | Sage Therapeutics Inc | Composizioni e metodi per trattare disturbi del snc |
| SMT202100113T1 (it) | 2015-01-26 | 2021-05-07 | Sage Therapeutics Inc | Composizioni e metodi per trattare disturbi del snc |
| JP6875996B2 (ja) | 2015-02-20 | 2021-05-26 | セージ セラピューティクス， インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
| AU2016274690B2 (en) | 2015-06-10 | 2020-05-21 | Boston Scientific Scimed, Inc. | Bodily substance detection by evaluating photoluminescent response to excitation radiation |
| WO2017156103A1 (en) | 2016-03-08 | 2017-09-14 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| NZ790187A (en) | 2016-07-11 | 2025-08-29 | Sage Therapeutics Inc | C7, C12, and C16 substituted neuroactive steroids and their methods of use |
| IL264129B2 (en) | 2016-07-11 | 2024-05-01 | Sage Therapeutics Inc | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| EP3728285A1 (en) * | 2017-12-22 | 2020-10-28 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| IL312610A (en) | 2018-12-05 | 2024-07-01 | Sage Therapeutics Inc | Neuroactive steroids and methods of using them |
| SG11202112391UA (en) | 2019-05-31 | 2021-12-30 | Sage Therapeutics Inc | Neuroactive steroids and compositions thereof |
| BR112021026447A2 (pt) * | 2019-06-27 | 2022-04-12 | Sage Therapeutics Inc | Composições e métodos para tratamento de distúrbios de cns |
| CN114729000A (zh) * | 2019-06-27 | 2022-07-08 | 萨奇治疗股份有限公司 | 用于治疗cns病症的化合物 |
-
1976
- 1976-01-06 GB GB357/76A patent/GB1570394A/en not_active Expired
-
1977
- 1977-01-05 NL NL7700054A patent/NL7700054A/xx not_active Application Discontinuation
- 1977-01-05 ZA ZA00770059A patent/ZA7759B/xx unknown
- 1977-01-05 AU AU21065/77A patent/AU513579B2/en not_active Expired
- 1977-01-05 FR FR7700171A patent/FR2361419A1/fr active Granted
- 1977-01-05 SE SE7700098A patent/SE7700098L/ not_active Application Discontinuation
- 1977-01-05 BE BE173855A patent/BE850108A/xx not_active IP Right Cessation
- 1977-01-05 DK DK3577A patent/DK3577A/da not_active Application Discontinuation
- 1977-01-05 DE DE19772700267 patent/DE2700267A1/de not_active Ceased
- 1977-01-05 JP JP30477A patent/JPS5285159A/ja active Pending
- 1977-01-05 CA CA269,161A patent/CA1084903A/en not_active Expired
- 1977-01-06 NZ NZ183004A patent/NZ183004A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1084903A (en) | 1980-09-02 |
| AU2106577A (en) | 1978-07-13 |
| BE850108A (fr) | 1977-07-05 |
| JPS5285159A (en) | 1977-07-15 |
| NL7700054A (nl) | 1977-07-08 |
| AU513579B2 (en) | 1980-12-11 |
| DE2700267A1 (de) | 1977-07-14 |
| GB1570394A (en) | 1980-07-02 |
| FR2361419B1 (OSRAM) | 1980-04-04 |
| NZ183004A (en) | 1980-03-05 |
| DK3577A (da) | 1977-07-07 |
| ZA7759B (en) | 1978-02-22 |
| FR2361419A1 (fr) | 1978-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7700098L (sv) | Bedovningsmedel och forfarande for framstellning derav | |
| GB1534823A (en) | Dental chairs or like patient supporting devices | |
| FR2347382A1 (fr) | 11a-amino, d4 ou d5 pregnanes et androstanes a groupe amino disubstitue | |
| AU508224B2 (en) | 9 21-dihalogeno-11 17 -dihydroxy-6 -fluro-16-methyl-pregna-1,4-diene-3,20-diones | |
| ATE18671T1 (de) | 17,17-bis(substituiert thio)-3-keto-androstene und pharmazeutische zusammensetzungen. | |
| BG41124A3 (en) | Method for preparing benzamides | |
| BG28849A3 (bg) | Метод за получаване на гамапирони | |
| AU570552B2 (en) | 1,4-dihydropyridine-3-carboxylates and salts thereof | |
| PT86228A (de) | Verfahren zur herstellung von 6alpha,9alpha-difluor-11beta,17alpha-dihydroxy-16alpha-methil-4-pregnen-3,20-dion und dessen derivate | |
| BG30174A4 (en) | Method of obtaining of bensolcarbamides | |
| BE840537A (fr) | Attenuation acoustique, inserable notamment dans un conduit d'air | |
| DK133382B (da) | Analogifremgangsmåde til fremstilling af 6alfa,9alfa-diflour-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-dien-3,20-dion-17,21-diacetat. | |
| JPS56122342A (en) | Phenylisourea derivative and its manufacture | |
| BG36633A3 (en) | Method for preparing 3- hydroxycephalosporines | |
| FI842894A0 (fi) | Foerfarande foer framstaellning av (8s)-8-fluoroerytromyciner. | |
| IT8023191A0 (it) | Uso farmacologico del 6-cloro-17idrossi 1 alfa, 2 alfa-metilpregna 4,6-dien-3,20-dione | |
| IE37597L (en) | 21-fluoro pregnanes. | |
| SU700723A2 (ru) | Косозуба зубчата передача | |
| ES465550A1 (es) | Procedimiento para la obtencion de halogenopregnadienos. | |
| SU711556A1 (ru) | Цифровой генератор функции | |
| SU666320A1 (ru) | Зубчата эластична муфта м.с.тривайло | |
| IT1239719B (it) | Uso dell'anticorpo monoclonale sp-2 nella diagnostica clinica ed il monitoraggio del progredire dell'infezione hiv | |
| FR2283100A1 (fr) | Melange a base de platre | |
| CA533865A (en) | ALLOPREGNANE-17.alpha.,21-DIOL-3,11,20-TRIONE ACETATE | |
| Andy | Katja Andy Concert (program) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7700098-2 |